Cerberus, Ignition Growth to sell PaxVax
Emergent BioSolutions is buying PaxVax from Cerberus Capital Management LP and Ignition Growth Capital for $270 million. PaxVax, of Redwood City, California is a specialty vaccines company. Perella Weinberg Partners LP acted as financial adviser to PaxVax. Covington & Burling LLP acted as legal counsel for Emergent. Dechert LLP is the attorney for PaxVax and Cerberus and Morgan Lewis & Bockius LLP acted as legal counsel for PaxVax.
9 August 2018•4 mins read
